Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine 1-8-1, Inohana, Chuou-ku, Chiba 260-8670, Japan.
Eur J Radiol. 2010 Jul;75(1):e102-6. doi: 10.1016/j.ejrad.2009.08.017. Epub 2009 Sep 23.
To elucidate the changes in tumor vascularity and microbubble accumulation on contrast-enhanced sonograms, in relation to the dedifferentiation of hepatocellular carcinoma (HCC).
This prospective study enrolled 10 patients with histologically proven HCC (14.4-39.0mm, 26.1+/-7.4) showing nodule-in-nodule appearance upon contrast-enhanced computed tomography. Contrast-enhanced ultrasound was performed by harmonic imaging under a low mechanical index (0.22-0.25) during the vascular phase (agent injection to 1 min) and late phase (15 min) following the injection of Sonazoid (0.0075 ml/kg). Contrast enhancement in the inner and outer nodules was assessed in comparison with that in adjacent liver parenchyma as hyper-, iso-, or hypo-enhanced.
Vascular-phase enhancement of all 10 inner nodules was hyper-enhanced, and that of outer nodules was hyper-enhanced in 3, iso-enhanced in 2, and hypo-enhanced in 5. Late-phase enhancement of inner nodules was hypo-enhanced in 8 and iso-enhanced in 2. Furthermore, late-phase enhancement of outer nodules was iso-enhanced in the 7 lesions that showed iso- or hypo-enhancement in the vascular phase, and hypo-enhanced in the 3 with hyper-enhancement in the vascular phase. Late-phase hypo-enhancement was significantly more frequent in the nodules showing early-phase hyper-enhancement (11/13) than in the nodules showing early-phase iso- or hypo-enhancement (0/7) in both the inner and outer nodules.
Dedifferentiation of HCC may be accompanied by changes in tumor vascularity prior to a reduction in microbubble accumulation. Observation of the vascular phase may be more useful than late-phase imaging for the early recognition of HCC dedifferentiation when using contrast-enhanced ultrasound with Sonazoid.
阐明与肝细胞癌(HCC)去分化相关的肿瘤血管变化和微泡积聚在对比增强超声中的变化。
本前瞻性研究纳入了 10 名经组织学证实的 HCC 患者(14.4-39.0mm,26.1+/-7.4),这些患者在对比增强 CT 上显示出结节内结节外观。在注射 SonoVue(0.0075ml/kg)后,在血管期(造影剂注射后 1 分钟)和晚期(15 分钟),通过低机械指数(0.22-0.25)进行谐波成像进行对比增强超声检查。与相邻肝实质相比,评估内、外结节的增强程度为高、等或低增强。
所有 10 个内结节的血管期增强均为高增强,而外结节的增强在 3 个为高增强,2 个为等增强,5 个为低增强。内结节的晚期增强在 8 个为低增强,2 个为等增强。此外,在外结节中,在血管期显示等或低增强的 7 个病变中晚期增强为等增强,而在血管期增强为高增强的 3 个病变中晚期增强为低增强。在外结节中,早期增强为高增强的结节(11/13)比早期增强为等或低增强的结节(0/7)更常出现晚期低增强,无论是内结节还是外结节。
HCC 的去分化可能伴随着肿瘤血管变化,然后才是微泡积聚的减少。当使用 SonoVue 进行对比增强超声检查时,观察血管期可能比晚期成像更有助于早期识别 HCC 的去分化。